Compare

Oaktree Acquisition Corp. III Life Sciences vs Dynamix Corp III vs Blue Acquisition Corp/Cayman vs Thayer Ventures Acquisition Corp II

Latest annual figures from SEC filings. Each company is shown for its own most recent fiscal year, so period ends can differ. Select a figure to see its full history.

Latest fiscal year	Oaktree Acquisition Corp. III Life Sciences OACC	Dynamix Corp III DNMX	Blue Acquisition Corp/Cayman BACC	Thayer Ventures Acquisition Corp II TVAI
Year ended	2025-12-31	2025-12-31	2025-12-31	2025-12-31
Revenue	n/a	n/a	n/a	n/a
Revenue growth (YoY)	n/a	n/a	n/a	n/a
Gross margin	n/a	n/a	n/a	n/a
Operating margin	n/a	n/a	n/a	n/a
Net margin	n/a	n/a	n/a	n/a
Net income	$7.29M	n/a	n/a	$3.88M
EPS (Diluted)	n/a	n/a	n/a	n/a
Operating cash flow	-$422.1K	n/a	n/a	$617.1K
Free cash flow	n/a	n/a	n/a	n/a
Cash & equivalents	$1.43M	$1.33M	$560.8K	$0
Total assets	$203.11M	$203.94M	$206.33M	$206.82M
Total liabilities	$8.32M	$8.30M	$8.12M	$8.64M
Shareholders' equity	-$6.77M	-$6.83M	-$7.43M	-$8.18M
Return on year-end equity	n/a	n/a	n/a	n/a
Shares outstanding	n/a	n/a	n/a	n/a

n/a means the company did not report that line under the concept TickerFacts maps, not that it is zero.

Revenue, most recent five fiscal years

Fiscal year	Oaktree Acquisition Corp. III Life Sciences	Dynamix Corp III	Blue Acquisition Corp/Cayman	Thayer Ventures Acquisition Corp II
Latest	n/a	n/a	n/a	n/a
1 year earlier	n/a	n/a	n/a	n/a
2 years earlier	n/a	n/a	n/a	n/a
3 years earlier	n/a	n/a	n/a	n/a
4 years earlier	n/a	n/a	n/a	n/a